| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.477 | 55.114 | 53.209 | 51.162 | 43.069 | 50.310 | 43.831 | 36.768 | 35.875 | 27.601 |
| Total Income - EUR | 50.661 | 55.293 | 53.211 | 51.175 | 43.138 | 50.376 | 43.851 | 36.773 | 35.877 | 27.698 |
| Total Expenses - EUR | 45.118 | 50.339 | 50.754 | 51.163 | 44.505 | 50.108 | 42.545 | 38.472 | 37.433 | 27.628 |
| Gross Profit/Loss - EUR | 5.544 | 4.953 | 2.457 | 12 | -1.367 | 269 | 1.305 | -1.700 | -1.555 | 70 |
| Net Profit/Loss - EUR | 4.038 | 3.846 | 1.905 | -513 | -1.808 | -33 | 1.068 | -2.017 | -1.913 | 59 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bionewvita Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 91 | 90 | 88 | 643 | 267 | 1.041 | 840 | 582 | 401 | 222 |
| Current Assets | 12.881 | 13.110 | 13.190 | 10.159 | 7.664 | 7.947 | 7.421 | 6.151 | 3.807 | 3.027 |
| Inventories | 12.674 | 12.740 | 12.763 | 10.132 | 7.640 | 7.726 | 7.282 | 6.002 | 3.464 | 2.880 |
| Receivables | 0 | 0 | 337 | 0 | 0 | 0 | 0 | 0 | 323 | 125 |
| Cash | 208 | 371 | 90 | 26 | 24 | 221 | 138 | 149 | 21 | 21 |
| Shareholders Funds | 8.824 | 3.908 | 5.747 | 5.129 | 3.221 | 3.127 | 4.125 | 2.120 | 201 | 258 |
| Social Capital | 54 | 53 | 53 | 52 | 51 | 50 | 49 | 49 | 49 | 48 |
| Debts | 4.148 | 9.292 | 7.531 | 5.673 | 4.710 | 5.861 | 4.136 | 4.612 | 4.007 | 2.990 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Bionewvita Srl